![Pharmacy Times](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/334/normal/Screen_Shot_2015-01-26_at_11.48.35.png?1422272928)
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer Hospitalizations
Pharmacy Times,
Based on the current pipeline, oral antineoplastic drugs will be the mainstay of cancer treatment in the next few years.1 This…